Results 71 to 80 of about 29,345 (146)

Triple Loop Atrial Flutter Occurring After a Lung Transplant. [PDF]

J Arrhythm
Yamada T.
europepmc   +1 more source

Assessing Major Adverse Liver Outcomes With Baclofen Compared to Acamprosate in Compensated Alcohol‐Associated Cirrhosis

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 12, Page 1673-1684, June 2026.
We conducted a nationwide, multicenter cohort study using a target trial emulation framework to compare baclofen and acamprosate in patients with compensated alcohol‐associated cirrhosis. After matching, baclofen initiation was associated with a higher 1‐year risk of major adverse liver outcomes, driven primarily by hepatic encephalopathy, particularly
Yee Hui Yeo, Sepideh Mehravar, Ellen Choi, Ju Dong Yang, Hyun‐Seok Kim, Yun Wang, Aarshi Vipani, Hirsh D. Trivedi, Walid Ayoub, Parnian Naji, Alexander Kuo, Chun‐Ying Wu, Lorenzo Leggio, Juan Pablo Arab   +13 more
wiley   +1 more source

Radiofrequency Ablation for Typical Atrial Flutter in Dextroversion With PLSVC and IVC Interruption. [PDF]

JACC Case Rep
Zheng H, Pei C, Li D, Li H, Xue L, Cai H.   +5 more
europepmc   +1 more source

Atrial stunning as a risk factor for thromboembolic events after cardioversion of atrial flutter. [PDF]

Eur Heart J Case Rep
Hahn L, Petersen-Uribe A, Nordt T, Roser E.   +3 more
europepmc   +1 more source

Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5163-5173, June 2026.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and sodium–glucose cotransporter 2 (SGLT2) inhibitors are widely used for the treatment of type 2 diabetes, yet their downstream consequences in routine clinical practice remain incompletely characterized.
Yazan Alhamdan, Jason C. Hsu, Christine Y. Lu   +2 more
wiley   +1 more source

Evaluation and Management of Recurrent Atrial Flutter in Neonates. [PDF]

J Clin Med
Aravindan N, Gaskin PRA, Vashist S.
europepmc   +1 more source

A Comprehensive Echocardiographic Assessment of Patients With Chronic Myeloid Leukemia on Dasatinib

Echocardiography, Volume 43, Issue 6, June 2026.
In a retrospective cohort of 199 adult patients with CML on Dasatinib in a single quaternary center, approximately 25% patients had routine baseline and follow‐up echocardiogram. Dasatinib was associated with significant changes in structural and diastolic parameters.
Chen Chen, Vinesh Appadurai, Maria Paulina Hernandez, Jessica Altman, Nausheen Akhter   +4 more
wiley   +1 more source

Intracardiac echocardiography-derived cavotricuspid isthmus morphology score for estimating procedural complexity in typical atrial flutter. [PDF]

Europace
Gabarin M, Abonab M, Acosta JG, Arow Z, Alfraih A, Amit G, Bonacina J, Alrasheed M, Roberts J, Tan N, Menon SD, Wong JA, McIntyre WF.   +12 more
europepmc   +1 more source

Real‐World Selection of Venetoclax‐Obinutuzumab Versus BTK Inhibitor Therapy for Treatment‐Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

European Journal of Haematology, Volume 116, Issue 6, Page 845-849, June 2026.
ABSTRACT Introduction Novel targeted agents have transformed the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), including continuous BTK inhibitor (BTKi) therapy and time‐limited regimens such as venetoclax‐obinutuzumab (Ven‐O) and ibrutinib‐venetoclax (I + V).
Rebecca Tidswell, Carolyn Owen, Mona Shafey, Sarah Perry, Nanette Cox‐Kennett, Russell Sterrett, Anthea Peters, Robert Puckrin   +7 more
wiley   +1 more source

Electrocardiographic Artifact Caused by Deep Brain Stimulation Mimicking Atrial Flutter in Patient With Contralateral Pacemaker. [PDF]

JACC Case Rep
Brazzano I, Pace V, Ceglia R, Gandotra P, Chinitz JS.   +4 more
europepmc   +1 more source